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Abstract
Background: Group A streptococcus (GAS) is the etiological agent of a variety of local and invasive infections as
well as post-infection complications in humans. This β-hemolytic bacterium encounters environmental heme in vivo in
a concentration that depends on the infection type and stage. While heme is a noxious molecule, the regulation of
cellular heme levels and toxicity is underappreciated in GAS. We previously reported that heme induces three GAS
genes that are similar to the pefRCD (porphyrin regulated efflux) genes from group B streptococcus. Here, we investigate
the contributions of the GAS pef genes to heme management and physiology.
Results: In silico analysis revealed that the PefCD proteins entail a Class-1 ABC-type transporter with homology to
selected MDR systems from Gram-positive bacteria. RT-PCR experiments confirmed that the pefRCD genes are
transcribed to polycistronic mRNA and that a pefC insertion inactivation mutant lost the expression of both pefC
and pefD genes. This mutant was hypersensitive to heme, exhibiting significant growth inhibition already in the
presence of 1 μM heme. In addition, the pefC mutant was more sensitive to several drugs and nucleic acid dyes
and demonstrated higher cellular accumulation of heme in comparison with the wild type and the complemented
strains. Finally, the absence of the PefCD transporter potentiated the damaging effects of heme on GAS building blocks
including lipids and DNA.
Conclusion: We show here that in GAS, the pefCD genes encode a multi-drug efflux system that allows the bacterium
to circumvent the challenges imposed by labile heme. This is the first heme resistance machinery described in GAS.
Keywords: Mutational analysis, Multi-drug exporter, Doxorubicin, Gram-positive, PefRCD, DNA damage detection,
Heme content
Background
Streptococcus pyogenes or Group A Streptococcus (GAS)
is a Gram positive, β- hemolytic, human pathogen trans-
mitted via respiratory droplets and direct contact. GAS
is responsible for a diverse spectrum of diseases ranging
from superficial (e.g., pharyngitis, impetigo and pyoderma)
to severe invasive infections and systemic manifestations
(such as necrotizing fasciitis and streptococcal toxic shock
syndrome). In addition, simple GAS infections can trigger
autoimmune reactions in some patients leading to neuro-
logical disorders, glomerulonephritis, or acute rheumatic
fever [1, 2]. GAS encodes a large collection of virulence
factors, which act to promote infections and pathologies
by various means such as bacterial adherence and inva-
sion, evasion of the host immune surveillance and nutrient
acquisition [3]. Due to the high morbidity associated with
GAS related illnesses, this pathogen is ranked 9th among
the world’s leading infectious agents [4]. Recent global
estimates suggest that every year about 600 million
GAS infections occur, accounting for ~ 600,000 deaths [5].
The reported increase in antibiotic resistance, emergence of
new strains, and absence of vaccine programs suggest that
the disease burden inflicted by GAS is likely to rise [6, 7].
GAS requires iron for growth and can retrieve the
metal from heme [8]. The cytolysins produce by GAS
provide the pathogen with access to the host intracellular
pool of hemoproteins. GAS proceeds with heme uptake
using the streptococcal iron acquisition (sia) operon: heme
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is extracted and captured on the bacterial surface by the
Streptococcal hemoproteins receptor (Shr), relayed to the
streptococcal hemoprotein (Shp), and subsequently to the
substrate binding protein, SiaA (HtsA). The SiaBC im-
porter then internalizes the heme [9–13]. Although heme
is nutritionally beneficial, its pro-oxidant nature renders it
hazardous in surplus quantities [14]. We recently observed
that exposure to sub-lethal heme concentrations elicits a
global stress response in GAS [15]. This observation un-
derscores the harmful potential of heme. Heme toxicity
seems particularly relevant to the patho-physiology of the
β-hemolytic pathogen, and could impose as a significant
challenge for GAS growth during invasive infections.
Heme-mediated cell injuries are primarily accredited
to the coordinated iron element. The dynamic existence
of iron in two redox and spin states within heme allows
it to react with multiple biological entities including pro-
teins, nucleic acids and lipids. This effect is exacerbated
by the participation of iron in Fenton reactions, which
lead to generation of radicals or reactive oxygen species
[16]. In addition to iron toxicity, the lipophilic nature of
the protoporphyrin-ring (PPIX) is associated with photo-
sensitivity and insertion of heme into membranes. This
process was shown to undermine membrane permeabil-
ity and further potentiates the release of free-heme from
erythrocytes [17, 18]. In mammalians, increased and per-
sistent flux of free-heme in the vascular system is associated
with significant inflammation and pathology [19].
To manage heme toxicity, bacteria carefully control
heme uptake according to cellular demands. In GAS for
example, a metalloregulatory protein named MtsR, directly
represses the expression of the sia operon in the presence
of iron [20]. In addition to limiting heme uptake, bacteria
employ various sequestration, degradation, and active efflux
mechanisms. The export of heme excess and its role in pro-
tection against toxicity has been increasingly recognized in
bacteria. The multiple-transferable-resistance (MtrCDE)
efflux system from Neisseria gonorrhea which, expels
hydrophobic antibacterial agents [21], also facilitate re-
sistance to PPIX, heme, and other porphyrin-based
compounds. Inactivation of the mtrCDE pump resulted
in increased gonococci sensitivity to porphyrins and
metalloporphyrins, while overexpression of this system
endowed cells with an increased tolerance to porphyrin
based compounds [22]. The E. coli MacAB pump is an-
other example of an active exporter with broad specificity
that contributes to heme tolerance. MacAB (with the TolC
outer membrane channel protein) enables eneterotoxin
secretion and confers resistance to macrolides [23, 24]. In
addition, MacAB-TolC serves as the major PPIX exporter
in E. coli [25].
In Gram-positive organisms, the archetype of an ex-
porter that mediates heme tolerance in several bacteria
including Bacillus anthracis and Lactococcus lactis was
identified first in Staphylococcus aureus and named
heme-regulated transporter (HrtAB) [26–29]. Work per-
formed in L. lactis suggested that this system exports
heme directly from the membrane, acting to limit heme
accumulation in this compartment [29, 30]. The expres-
sion of the hrtAB genes is tightly regulated according to
heme availability via the two-component system HssRS
(in S. aureus and B. anthracis) or the heme-dependent
repressor, HrtR (L. lactis) [28, 29, 31]. The presence of
the HrtAB transporter and the associated regulatory net-
work bestows bacteria with elevated heme sensing and
resistance capacity. Studies in a mouse infection model
demonstrated that the HrtAB promoter in B. anthracis
is induced in vivo, suggesting that the HrtAB transporter
is recruited during infection, presumably to alleviate
heme toxicity [28]. Interestingly, while both species ex-
hibit similar sensitivity to environmental heme, the loss
of hrtA in B. anthracis has a more pronounced impact
than in S. aureus, implying that heme sensing and/or de-
toxification by the HssRS and HrtAB systems are more
effective in B. anthracis than in S. aureus. [28]. The gen-
ome of Group B streptococcus (GBS) contains putative
hrtAB homologs that are regulated by heme availability.
However, contribution of these genes to heme efflux and
tolerance in GBS has yet to be determined. In addition,
GBS carries a regulon called porphyrin regulated efflux
(pef ) whose expression is controlled by PefR, a MarR-like
repressor [32]. Heme or PPIX allow for transcriptional ac-
tivation of the pef regulon by relieving PefR binding to its
operator. The pef regulon consists of at least two separate
gene clusters (pefAB and peRCD) that encode two distinct
transporters, pefAB and pefCD. Inactivation of the GBS
pef transport system results in increased sensitivity to
heme and intracellular buildup of heme and PPIX. Over-
expression of these systems led to heme depletion and a
defect in both respiratory metabolism and virulence [32].
In Listeria monocytogenes, an ATP-dependent transporter,
FrvA (Fur regulated virulence factor A), was implicated in
heme export and protection from heme toxicity [33]. Not-
ably, the FrvA transporter is essential for the systemic in-
fections in mice models.
Mechanisms of heme tolerance are poorly understood
in GAS. We recently identified a three-gene cluster in
GAS that shares significant similarity to the GBS pefRCD
genes. We demonstrated that these genes are up regulated
in response to heme exposure and implicated the PefR
homolog in heme sensing and regulation of the gene clus-
ter [15]. In this study, we set to determine the function of
the pefCD genes in GAS physiology.
Results
The pefCD genes encode a conserved Class-1 ABC exporter
We recently reported the transcriptional activation of a
3-gene cluster (MGAS5005 spy_0195, 0196, and 0197)
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ensuing GAS exposure to environmental heme. We
named these GAS genes as pefRCD based on similarity
in genetic organization, primary sequence, and regula-
tion to the previously described pefRCD operon in GBS
[15, 32] (Fig. 1a). Our analysis here showed that the
pefRCD genes are highly conserved among GAS strains
exhibiting 100 % identity for PefR, 98 % identity for
PefC, and 99 % identity for PefD protein (for all 20
strains in the database). The pefCD genes are annotated
in GAS genome as the subunits of a putative multi-drug
resistance (MDR) system. Sequence examination indi-
cated that the pefCD genes code for the two subunits of
a heteroligomeric ATP-dependent exporter. Both ORFs
contain, at the N terminus, an integral membrane (IM)
permease domain from the superfamily of ATP binding
cassettes fused to an ATP-hydrolyzing domain (ABC,
also referred to as the nucleotide binding domain). This
domain organization is of the Class-1 ABC-type trans-
porter family [34]. This transporter class is comprised of
systems with fused IM and ABC domains and contains
the vast majority of ABC-type export systems [34]. Our
recent BLAST analysis against the transporter classifica-
tion (TC) database (http://www.tcdb.org) [35] revealed
that the PefCD proteins consists of a transporter from
the Drug Exporter-4 sub class (3.A.1.135). Importantly,
this analysis revealed that PefCD exporter is identical to
a previously described transporter from the GAS strain
JRS4, named Rsc (regulated by stress and Cov) after its
regulation by the response regulator CovR [36]. The sub-
strate (s) of the Rsc system was not identified but the
transporter was found to be required for bacterial
growth at high temperature. The nearest relatives of the
PefCD (RscAB) proteins are the components of the
MDR transporters, SatAB of S. suis [37], PatAB from S.
Fig. 1 The pefRCD genes entail an operon prevalent in human and zoonotic streptococci. a The genomic arrangement and occurrence of the
pefRCD genes in GAS (MGAS5005 strain) and GBS (NEM316 strain) is also conserved among members of the pyogenic cluster namely, S. equi
(4047 strain), S. uberis (0140 J strain), and S. iniae (ISET0901). Additionally, this system is found in S. suis (JS14 strain). These PefCD homologs are
referred to as SatAB in the literature [37]. The pef operon consists of a MarR-like transcriptional regulator (locus tag for strains tested: Spy_0195,
gbs1402, SEQ_0290, SUB_1690, SSUJS14_1996, and DQ08_09375) controlling an adjacent ABC-type efflux system (Spy_0196-97, gbs1401-00,
SEQ_0292-93, SUB_1689-88, SSUJS14_1995-94, and DQ08_09370-65). The neighboring genes upstream and downstream from the pef operon
consist of lipid metabolism (gpsA) and unknown function, respectively. b The GAS pefRCD genes are co-transcribed. RT-PCR analysis was
preformed with 0.8 μg RNA extracted from NZ131 strain. cDNA synthesized by use of the pefD antisense primer (ZE650), was amplified by
PCR with gene specific primers and fractionated on 1.2 % agarose gel (lanes 2, 5, and 8). PCR was also conducted using genomic DNA
(lanes 3, 6, and 9) or RNA (without RT reaction, lanes 4, 7, and 10) as templates. Fragments from the following genes were amplified: pefR,
lanes 2, 3 and 4; pefC, lanes 5, 6 and 7; and pefD, lanes 8, 9, and 10. The lines above the gene diagram in Figure-1A depict the amplified regions and
the primer sets used in the PCR are included on top. The sizes of molecular mass standards are indicated to the left of the gel
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pneumonia [38], and LmrCD (aka YdaG and YdbA) from
L. lactis [39]. For simplicity we continue in this manu-
script to refer to the GAS exporter as the PefCD system.
Further in-silico study performed on genomes of strepto-
cocci identified putative homologs of the pefRCD gene
cluster in S. equi, S. uberis, S. suis and S. iniae [40–44].
A high degree of conservation in genetic organization
and sequence exhibiting 54 % amino acid similarity for
the PefR, 60 % for the PefC, and 64 % for the PefD protein
among all the candidates tested by ClastalW pairwise
alignment tool [45]. (Fig. 1a).
The GAS pefRCD genes entail a heme-induced operon
The pefRCD locus is preceded with a 300 bp intergenic
region and consists of three overlapping ORFs oriented
in the same direction on the direct strand in GAS gen-
ome. This genetic organization and the co-regulation by
heme indicate that the pef locus is an operon. We used
RT-PCR analysis to test this suggestion (Fig. 1); RNA
was extracted from NZ131 strain after heme exposure
and cDNA was synthesized with a primer specific to the
complementary strands of pefD. The genes encoded by
the produced cDNA were subsequently detected by PCR
analysis with gene specific primers (see Materials and
Methods). These experiments demonstrated that the
cDNA produced with the pefD primer codes for pefD,
pefC as well as pefR (Fig. 1b, lanes 2, 5, and 8), establishing
that the pefRCD cluster expresses a polycistronic mRNA.
No products were observed when total RNA (without RT
reaction) was used as a template.
Construction of a polar mutation in pefC
In order to gain insights into the role of the pefCD genes
in GAS physiology, we created a polar mutation in pefC
by Campbell insertion (ZE4951 strain) in the background
of the wild type strain, NZ131 (Table 1 and Fig. 2a). The
formation of the pefC::pMZ1 mutation was confirmed by
PCR analysis. This analysis established the presence of the
specR cassette in ZE4951 chromosome (the 0.7 kb band in
lane 9, Fig. 2b). In addition, these experiments verified the
formation of the two expected plasmid/chromosome junc-
tions; specifically, the region spanning specR and down-
stream up to the pefR gene (the 2.5 kb band in lane 3,
Fig. 2b) and the region covering specR and upstream up to
the pefC portion that is outside of the fragment that was
cloned into pMZ1 (the 3.5 kb band in lane 6, Fig. 2b). The
same PCR reactions did not produce any product when
performed with the chromosomal DNA of the parental
strain, NZ131 (lanes 4 and 7 in Fig. 2b). Together, this
analysis confirmed that pMZ1 integrated into the correct
site in the chromosome forming ZE4951 strain.
To evaluate the effect of the pefC mutation on gene
expression, we preformed Q-PCR analysis with total RNA
extracted from the wild type (NZ131) and the mutant
(ZE4951) strains after exposure to heme (Fig. 2). The tran-
script level of pefC (after the insertion site) was reduced to
0.9 % and that of pefD to 0.3 % of the level observed in
the parental strain (Fig. 2c). Therefore, inactivation of
pefC in ZE4951 effectively ensued in the loss of the
pefCD transporter.
Inactivation of the pefCD system resulted in a growth
phenotype and heme hypersensitivity
For complementation analysis, we cloned the pefRCD
operon with its native promoter into a shuttle vector
(pKSM201). E. coli cells harboring the plasmid carrying
the GAS pefRCD operon (pANKITA5b) did not exhibit
any growth phenotype. However, despite our multiple at-
tempts, we failed to create a sub clone that expresses
only the pefCD genes (under the pef promoter). We
therefore used the entire pefRCD operon (carried by
pANKITA5b) to complement the ZE4951 mutant (Table 1).
Analysis of ZE4951 growth in THYB media demonstrated
that inactivation of the pef system led to a pronounced
phenotype; the mutant cells grew slower and reached the
stationary phase of growth at a lower cell density in com-
parison to the isogenic NZ131 wild type strain (Fig. 3a). In
addition, cell viability of the mutant strain was significantly
reduced during overnight incubation in stationary phase
(data not shown). The growth defect of the ZE4951 mutant
was reversed in the presence the pefRCD genes expressed
in trans (pANKITA5b) but not in the presence of an empty
Table 1 Lists of bacterial strains and plasmids used in this study
Strain name Characteristics References
S. pyogenes
NZ131 M49 serotype isolated from acute
post-glomerulonephritis infection
[57]
ZE4951 NZ131 derivative with pefC::pMZ1
mutation
This study
ZE4951/pANKITA5b ZEM4951 strain complemented
with pefRCD locus expressed from
plasmid pANKITA5b
This study




DH5α hsdR17 ecA gyrA endA1 relA1 [58]
Plasmids
pMZ1 pUC-Spec derivative containing pefC
internal fragment and the spec
resistance gene aad9
This study
pKSM201 Shuttle vector containing the
kanamycin resistance gene aphA3
[56]
pANKITA5b pKSM201 derivative carrying the
pefRCD genes
This study
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shuttle vector (pKSM201, Fig. 3a). This analysis suggests
that the pefCD genes are required for optimal GAS growth
in standard laboratory medium.
When tested for heme sensitivity, the ZE4951 mutant
strain exhibited a larger zone of clearance around a
heme-submerged disc compared with the wild type
strain (Table 2). The mutant sensitivity to heme was re-
stored to the wild type level when complemented in
trans with the pefRCD genes, but not in the presence of
the control plasmid. To further elaborate on the impact
of PefCD loss, we compared the growth of the ZE4951
mutant (with empty vector) to that of the complemented
strain in THYB containing heme in varying concentra-
tion (Fig. 3b-c). We previously determined that the heme
MIC of the parental strain NZ131 is 10 μM [15]. In con-
trast, the growth of the ZE4951 mutant was significantly
reduced already in the presence of 1 μM heme (Fig. 3b),
and minimal growth was observed with 5 μM heme
(Fig. 3c). The complemented strain grew at normal level
in 1 μM heme, lower growth was seen in 5 μM heme,
and similar to the wild type NZ131 strain, no significant
growth was observed with 10 μM heme. These observa-
tions establish that the PefCD transporter is required for
GAS to thrive in heme containing medium.
The PefCD transporter is an MDR system that confers
resistance to nuclear stains, antibiotics, and
chemotherapeutic agents in addition to heme
The observations described above supported the hypothesis
that PefCD consists an efflux system that extrudes heme or
heme-related toxic metabolites. While some exporters are
selective for a given substrate, many are able to expel a
range of structurally unrelated molecules [34, 46]. To test
the specificity of the PefCD system we examined the impact
of PefCD loss on GAS sensitivity to a variety of structurally
unrelated compounds. These included the anthracyclic
compound doxorubicin, the antibiotics ampicillin, erythro-
mycin and norfloxacin, as well as the nucleic acid stains
ethidium bromide and Hoechst 33342 (Table 2). In com-
parison to wild type strain, the pefC mutant exhibited a
larger zone of inhibition around disc containing each of
Fig. 2 The construction of a polar mutation in pefC. a Schematic representation of the pefC::pMZ1 mutation in ZE4951 strain. The lines below the
locus diagram denote the DNA fragments amplified by the analysis described in section B. The lines above the diagram denote the products the
Q-PCR described in section C. SpecR signifies the spectinomycin resistance aad9 gene and ori represents pMZ1 origin of replication. The black
regions in the pefC gene denote the internal fragment that was cloned into pMZ1 and is thus duplicated in the mutant chromosome. b PCR
analysis of the pefRCD locus in the ZE4951 mutant. DNA was amplified by PCR and fractionated on 0.8 % agarose gel. The DNA ladder is shown
in lane 1. For the analysis of the left chromosome/plasmid junction the reactions were done with the ZE553/SpecFw primer set and genomic
DNA of NZ131 (lane 2), ZE4951 (lane 3), or no DNA (lane 4). For the right plasmid/chromosome junction, the reactions consist of the ZE554/SpecRev
primer set and genomic DNA of NZ131 (lane 5), ZE4951 (lane 6), or no DNA (lane 7). For the specR cassette, the reactions were preformed with the
SpecFW/SpecRev primer set and genomic DNA of the NZ131 (lane 8), ZE4951 (lane 9), pMZ1 (lane 10, positive control), or no DNA (lane 11). c Relative
expression of the pefC and pefD genes in ZE4951 and NZ131 strains. Total RNA was extracted and the relative expression of the pefC and pefD genes
was evaluated by Q-PCR. The relative expression of the pefC and pefD genes was normalized to rpsL transcript levels. The asterisk (*) indicates P value of
statistical significance (P <0.05) tested using student t-test (assuming equal variance) at 0.05 levels of significance
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the compounds mentioned above, other than norfloxacin.
As with the sensitivity to heme, the drug hypersensitivity
phenotype was reversed when the pefRCD genes were sup-
plied in trans (Table 2). These data are consistent with the
in silico analysis that revealed homology between the
PefCD proteins and bacterial MDR systems.
Inactivation of the pefCD system is associated with elevated
levels of heme-induced damage to cellular constituents
In order to uncover why the loss of the pefCD genes leads
to reduced heme tolerance in GAS, we investigated the im-
pact of heme on GAS cellular components in the wild type
and mutant strains. In a recent study we demonstrated that
Fig. 3 Insertion inactivation of pefC in GAS leads to impaired growth and heme hypersensitivity. a Growth of the NZ131 (WT), ZE4951 (Mutant),
ZE4951/pANKITA5b (Complement), and ZE4951/pKSM201 (Empty vector) strains in THYB. Fresh media were inoculated with GAS cells
(OD600 nm = 0.05) and the cultures were grown statically at 37 °C. Cell growth was monitored colorimetrically and expressed in Klett units.
b-c: Growth of ZE4951/pANKITA5b (Complement) and ZE4951/pKSM201 (Empty vector) strains in THYB containing varying heme concentration. The
same as with A, only that heme was added to the culture at the early logarithmic phase in final concentration of: b 1 μM; c 5 μM; and d 10 μM. The
data are representative of at least two independent experiments
Table 2 Determination of compound sensitivity by disc diffusion assay
Compounds Zone of clearance (mm)
WT (NZ131) Mutant (ZE4951) Complement (ZE4951/pANKITA5b) Control (ZE4951/pKSM201)
Heme 11.8 ± 1.4 15.8 ± 1.53a 9 ± 0.23 13 ± 0.31b
Doxorubicin 16 23 ± 1.25a 17 ± 0.19 22 ± 1.27b
Ethidium Bromide 22.5 ± 0.7 28.8 ± 0.35a 24 29 ± 1.4b
Hoechst 33342 18 22.8 ± 0.3a 19.5 ± 1.8 23.2 ± 1.0b
Ampicillin 44.8 ± 1.8 50.7 ± 1.1a 45.5 ± 0.8 49.7 ± 1.15b
Erythromycin 32 ± 1.0 38.7 ± 0.57a 33.3 ± 1.5 40.33 ± 1.52b
Norfloxacin 14 14 14.25 ± 0.35 13.75 ± 0.35
The letters ‘a’ and ‘b’ represent P values of statistical significance at 0.05 level of significance calculated using student t-test (of equal variance). The statistical
significance was evaluated by comparing WT with Mutant & Complement with Control data set
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exposure to low heme concentration was sufficient to dam-
age the lipids in GAS envelope [15]. Oxidized lipids react
with a thiobarbituric acid (TBA) reagent to form adducts
(named TBARS) that can be monitored by spectroscopic
methods and quantify with a standard curve [15, 47]. We
compared the time course of TBARS formation between
the wild type and mutant strain after the addition of 1 μM
heme into the culture (Fig. 4). Analysis of samples collected
30 min post exposure revealed that the ZE4951 mutant ex-
hibited higher level of lipid damage than the wild type
strain (3 versus 1.5 nmol/ml TBRAS in the mutant and
wild type strain respectively). Complementation of the pefC
mutation with the pefRCD genes resulted in a significantly
lower level of TBARS formation, in comparison to mutant
cells harboring the negative control plasmid (0.97 and
2.49 nmol/ml respectively). Interestingly, the TBARS levels
in the complemented mutant strain were reduced over time
(from 0.98 to 0.38 nmol/ml in the 30 and 90 min samples
respectively), while they remained approximately the same
in the wild type, mutant, and the mutant cells harboring
the control plasmid. Together these observations imply that
the PefCD system defends GAS from heme-induced lipid
damage and suggest that the expression of pefRCD genes
under our experimental conditions may be limiting in the
wild type strain.
Studies performed with eukaryotic systems showed
that heme could harm nucleic acids [48]. We asked if
environmental heme can damage GAS genome and if the
pef system offers protection from this harm. The repair of
chemically altered bases (due to oxidation, deamination or
alkylation) in the DNA is often mediated by repair mecha-
nisms that involve the formation apurinic/apyrimidinic
(AP) sites. Therefore, the amount of AP sites serves as a
good indicator for DNA damage and repair. To quantitate
the formation of AP sites in GAS chromosome, we used a
reagent (ARP) that reacts specifically with the aldehyde
group in the open ring form of the AP sites [49]. Chromo-
somal DNA was extracted from culture samples that were
harvested at different time points and was allowed to react
with ARP reagent. The formation of AP sites was detected
by ELISA and quantified using a standard curve (Fig. 5).
Analysis of chromosomal DNA from culture samples of
the wild type strain collected 30 min after the addition of
heme revealed about 90 % increase in the number of AP
sites compared to the background level (11 and 5.8 AP
sites per 105 bp respectively). The AP sites level was re-
duced over time, but remained 40 % above the
Fig. 4 The PefCD transporter protects GAS from heme-mediated
lipid oxidation. Cultures of NZ131 (WT), ZE4951 (Mutant), ZE4951/
pANKITA5b (Complement), and ZE4951/pKSM201 (Empty vector)
strains were treated with 1 μM heme during the mid logarithmic
phase of growth (60–70 Klett units). Culture samples were then
collected at 30, 60, and 90 min post-heme exposure and allowed to
react with TBA. The sample absorption at 532 nm was determined,
and the formation of TBA-reactive-substances (TBARS) was calculated
using the standard curve shown in A. All samples were standardized
with respect to cell number. The data are derived from two
independent experiments, each done in triplicates. The asterisk
(*) denotes that the observed P value is statistically significant
(P < 0.05) calculated using student t-test (equal variance) at 0.05
levels of significance
Fig. 5 The PefCD transporter protects GAS chromosome from heme-
mediated damage. Cultures of NZ131 (WT), ZE4951 (Mutant), ZE4951/
pANKITA5b (Complement), and ZE45/pKSM201 (Empty vector) strains
were treated with 5 μM heme during the mid logarithmic phase of
growth (60–70 Klett units). Genomic DNA was extracted from samples
collected at 0, 30 and 90 min post exposure was allowed to
react with ARP-biotin and analyzed. The sample absorption at
650 nm was determined and AP site formation was calculated
using the standard curve shown in A. All samples were standardized
with respect to cell number. The data are derived from two independent
experiments each done in triplicates. The asterisk (*) denotes that the
observed P value is statistically significant (P< 0.05) and is calculated
using student t-test (equal variance) at 0.05 levels of significance
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background (8 AP sites per 105 bp) in the samples col-
lected 90 min after treatment. Interestingly, in pefC mu-
tant the background level of AP sites was about twice as
high compared with the wild type strain (11.5 AP sites per
105 bp). Heme exposures resulted in a transient 117 % in-
crease in the number of AP sites, which was reduced to
background level within 60 min (25 and 11.5 AP sites per
105 bp in the 30 and 90 min respectively). The high AP
levels observed in the mutant strain were complemented
to those observed in the wild type strain by the pefRCD
genes expressed from a plasmid in all samples. The levels
of AP sites in the mutant strain carrying the empty vector
were comparable to that of the mutant strain alone. These
experiments indicate that environmental heme led to
DNA damage in GAS and that the pefCD genes offered
protection from DNA damage during growth in laboratory
medium as well as in medium containing externally added
heme. In addition, our data highlights the presence of
DNA repair mechanisms in GAS.
The PefCD system prevents cellular heme accumulation
One interpretation of the experiments described above
is that following the addition of heme to the culture
medium GAS cells absorb it in surplus amounts; in the
absence of a functional PefCD system, the bacterium accu-
mulates heme or heme-related metabolites that damage
the cell constituents. To directly test this hypothesis, we
examined the cellular heme content by the acidified
chloroform extraction method [50] described in the ma-
terial and methods (Fig. 6). Culture samples of equal cell
density were collected 90 min after the addition of 3 μM
heme to the medium and the cells were washed exten-
sively to remove surface bound heme prior to heme ex-
traction. The presence of heme in the organic phase of the
cell extracts was examined by spectroscopic analysis and
the concentration of the extracted heme from each sample
was extrapolated from a standard curve (Fig. 6b and d).
We extracted in these experiments about 30 % more heme
from the pefC mutant in comparison to the wild type
strain. The heme concentration obtained from cells of the
pefC mutant complemented with the pefRCD genes, was
7 % lower than that extracted from the wild type cells. On
the other hand, the presence of the empty vector did not
have a significant impact on the heme concentration in
the extract from the pefC mutant. Therefore, the PefC ac-
cumulates more heme then the wild type strain. This ob-
servation suggests that the PefCD system expels surplus
heme from GAS cells.
Discussion
Heme is an important nutrient for the β-hemolytic GAS,
which uses it in order to obtain iron within the host en-
vironment [8]. Despite its nutritional value, heme is a
harmful molecule that is damaging to GAS envelope
even in low concentrations [15]. In the current study, we
investigated how GAS manages the toxic challenges im-
posed by environmental heme. We recently identified a
3-gene cluster that was induced by heme and named it
after the pefRCD system in GBS [15, 32]. Following up on
our initial observations, we demonstrated that pefRCD
genes entail an operon and carried out a functional
characterization of the pefCD genes in the GAS strain,
NZ131. We established that pefCD encode an MDR ex-
porter that plays an important role in heme tolerance. The
PefCD proteins defend GAS membrane and chromosome
from the toxic effects of heme stress and prevent heme
accumulation in the bacterial cells. This is the first
heme tolerance pathway to be described in GAS.
To examine the role of the pefCD genes in GAS, we
created a polar mutation in pefC, which we then supple-
mented with the pefRCD genes expressed from a plas-
mid (since we could not clone pefCD under the native
pef promoter in the absence of pefR). The observed
heme related phenotypes of the pefC mutant were effect-
ively complemented. These observations indicate that
under our experimental conditions, the PefCD proteins
are expressed in trans at a level that is sufficient to miti-
gate the negative impact of heme. Our failed attempts to
clone pefCD in the absence of pefR, raises the possibility
that the constitutive expression of the pefCD genes is
detrimental to E. coli. Toxicity of membrane proteins
when overexpressed or of proteins expressed in heterol-
ogous hosts is not uncommon. A similar problem was
reported for the related SatAB system of S. suis [37].
Examining the phenotype of the pefC mutant and the
complemented strain showed that the loss of the PefCD
system led to increased sensitivity to heme and to five
structurally unrelated drugs (Table 2). This observation
is consistent with the bioinformatics analysis that re-
vealed significant similarity among PefCD proteins and
the confirmed MDR transporters SatAB, PatAB, and
LmrCD from S. suis, S. pneumoniae and L. lactis re-
spectively [37, 39, 51]. Together, these findings indicate
that the PefCD proteins consist of a MDR transporter
that expels antimicrobial compounds as well as heme or
heme related metabolites. Our additional findings dem-
onstrated that GAS accumulates heme in the absence of
a functional PefCD transporter (Fig. 6), strongly impli-
cating heme as one the substrates of the pefCD system.
The pefC mutant exhibited growth attenuation in THYB
(Fig. 3a). THYB contains infusions of brain and heart tis-
sues. Therefore, the mutant growth phenotype might
have resulted from increased sensitivity to the heme that
is already present in the medium. Alternatively or in
addition, PefCD may help in the clearance of other toxic
molecules that are generated during growth. Interestingly,
a previous study performed in the JRS4 strain revealed
that the pefC (rscA) gene is induced at low pH and by heat
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stress and that a pefC mutant could not grow at 40 °C.
The growth phenotype at a high temperature raised the
possibility that the pefCD proteins export molecules that
harm the membrane structure and fluidity [36]. Heme
could be such a molecule, since it is known to penetrate
membranes and undermine the membrane permeability
[30, 52]. Alternatively, other compounds exported by
PefCD may be responsible for this phenotype.
We previously reported that the addition of 4 μM
heme to the culture medium produced oxidative damage
Fig. 6 Inactivation of the pefCD transporter leads to cellular accumulation of heme in cells grown in the presence of heme. a UV-visible spectra
across wavelengths (250–700 nm) were recorded for organic fractions recovered after acidified chloroform extraction performed on a range
of hemin chloride standards. b The observed absorbance at 388, 450, and 330 nms from UV scans (of organic fractions) were plugged into
Ac = 2A388 − (A450 + A330) equation. The Ac values for standards extracted using chloroform for a range of hemin concentrations (0–4 μM, with
0.5 μM increments) were plotted against its hemin concentrations to generate a standard plot. The line equation of a standard plot was used
to extrapolate hemin concentrations in the experimental samples. Cultures of NZ131 (WT), ZE4951 (Mutant), ZE4951/pANKITA5b (Complement), and
ZE4951/pKSM201 (Empty vector) strains were treated with 3 μM heme during the mid logarithmic phase of growth (60–70 Klett units). Cells were
harvested, washed, and were subjected to chloroform extraction. c UV-visible spectra across different wavelengths (250–700 nm) of the collected
organic phases from tests samples were recorded. d Heme concentration in the test samples. The concentrations of heme in the test samples were
calculated using the standard curve shown in B. The data are derived from two independent experiments each done in triplicates. The asterisk
(*) denotes that the observed P value is statistically significant (P < 0.05) calculated using student t-test (equal variance) at 0.05 levels of significance
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in the envelope of the invasive MGAS5005 strain [15].
In this work, we made similar observations with the
nephritogenic NZ131, and showed that exposure to
1 μM heme led to noticeable levels of lipid peroxidation
(Fig. 4). Moreover, we showed for the first time that ex-
ternally added heme is also damaging to GAS chromo-
some (Fig. 5). Together, these observations highlight the
destructive impact of environmental heme on GAS cel-
lular components even at relatively low concentrations.
A number of observations demonstrate the importance
of the PefCD system in heme detoxification and suggest
a positive correlation between the expression of pefCD
system and detoxification capacity: 1) The pefC mutant
experienced more lipid and DNA damage comparing
with the wild type strain after heme treatment (Figs. 4
and 5). 2) The level of lipid peroxidation in the wild type
strain remained constant for 30–90 min post treatment,
while it was reduced over time in the complemented
strain (Fig. 4). 3) More AP sites were detected in the
chromosome of the pefC mutant comparing to the wild
type strain even in the absence of externally added
heme. 4) Heme begins to accumulate in the mutant cells
after its addition to the growth medium (Fig. 6d). The
pef regulon in GBS is induced by levels of heme that are
lower than those required to fully activate the putative
HrtAB transporter; it was therefore suggested that the
Pef exporters allow for adjustments in small variations in
heme and PPIX concentrations under different physio-
logical conditions while the Hrt exporter may be needed
to defend GBS against higher heme concentrations [32].
Here, we established that the PefCD system in GAS is re-
sponsive to low levels of environmental heme (1–5 μM)
and participate in the detoxification process. To the best
of our knowledge, a functional HrtAB-like transporter was
not described in GAS up to date. Nevertheless, GAS gen-
ome contains putative ABC transporters that belong to
the same transporter class as HrtAB. It is possible, that
like with GBS, these or other transporters are recruited in
GAS at higher heme concentrations in addition to PefCD.
GAS is a versatile pathogen that exhibits wide tissue
tropism and adaptability that enables it to inhibit not
only the epithelia of the skin and mucous membranes,
but also to flourish within soft tissues, the lymphatic
system, and the blood [2]. Therefore, depending on the
nature and stages of infection, GAS is expected to con-
front a wide spectrum of heme concentrations, ranging
from low amounts (e.g., during simple skin or mucosal
infection) to very high concentrations (such as during
invasive infections associated with significant erythrocyte
lysis and tissue destruction). Furthermore, heme tolerance
varies among GAS isolates with highly invasive strains
such as MGAS5005 showing higher resistance (Heme
MIC = 50 μM) than strains that are typically associated
with local infections such as NZ131 (MIC = 10 μM) [15].
We propose that the PefRCD represent a fundamental
heme defense pathway that is shared by all GAS strains,
safeguarding the organism against environmental heme.
Highly invasive strains may carry additional pathway (s)
that might confer increased resistance.
The role of active export in the management of heme
(and other porphyrins) levels and toxicity in bacterial
systems is not fully appreciated and only few systems have
been described up to date. Two systems were identified in
Gram-negative bacteria (MacAB/TolC and MtrCDE for E.
coli and N. gonorrhoeae, respectively) [22, 25, 53]. Both ex-
porters consist of cytoplasmic transporters that connect
via a membrane fusion protein to an outer membrane
channel/tunnel protein. Both cytoplasmic transporters are
MDR systems that export a number of compounds in
addition to heme and/or porphyrins. However, MacAB is
an ATP-type transporter while MtrC belongs to the Resist-
ance/Nodulation/Division (RND) family of transporters,
which uses the proton motive force for energy-dependent
export. In Gram-positive bacteria, four types of energy
dependent exporters used for heme and/or PPIX detoxifi-
cation were described (Fig. 7 portrays the heme trans-
porters described in streptococci). Intriguingly, HrtAB,
which was first identified in S. aureus [27], belongs to the
MacAB family of ABC-type efflux carriers. In this family
of ABC transporters, the membrane permease (IM) and
the ATPase (ABC) domains are encoded by separate
polypeptides (Class 3) [34]. HtrAB mediates heme tol-
erance in a number of Gram-positive bacteria. It was
shown to pump heme directly out of the membrane
compartment in L. lactis [30] and it is likely that it
functions in a similar manner in the other Gram-posi-
tive species. In L. monocytogensis, a P-Type ATPase, that
displays homology to bacterial heavy-metal transporting
ATPases, confers resistance to heme and hemoglobin [33].
The two other types of transporters were described first in
GBS: PefAB (antiporter) belongs to the MFS family that
relies on the proton motive force and PefCD, which is a
Class I, ABC-type transporters [32]. In this study, we
showed that the GAS PefCD system contributes to toler-
ance against both heme and a wide range of antimicrobial
compounds. The involvement of the other transporters
from Gram-positive bacteria in resistance to compounds
other than porphyrins was not examined.
Methods
Bacterial strains and growth conditions
Plasmids and strains used in this study are listed in Table 1
and the primers are described in Table 3. E. coli cells were
used for cloning and propagation of plasmids. E. coli was
grown aerobically in Luria-Bertani medium (BD) at 37 °C
(pH 7.0). GAS was grown under static conditions in
Falcon tubes or nephelometer flasks in Todd-Hewitt broth
(TH broth, Difco laboratories) with 0.2 % (weight/volume)
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yeast extract (BD). GAS ZE4951 mutant and the comple-
mented strains (carrying pANKITA5b or pKSM201) were
grown with Spectinomycin or with Spectinomycin and
kanamycin, respectively. Growth was measured using a
Klett-Summerson colorimeter (A filter) and/or by viable
counting. In some cases, hemin chloride (Sigma) prepared
in DMSO (0.035 % final concentration, Fisher BioRea-
gents) was added to the cultures. Spectinomycin was used
at 100 μg/ml for both E. coli and GAS, and kanamycin at
70 μg/ml for E. coli and 300 μg/ml for GAS.
Nucleic acid methods
The nucleic acid methods were performed with kits and
enzymes according to the manufacture’s instruction, unless
specified otherwise. DNA manipulations: Chromosomal
and plasmid DNA extraction and DNA manipulations were
done according to standard protocols and as previously de-
scribed [54]. Plasmid DNA was isolated from E. coli using
the Wizard Plus SV mini-prep system (Promega). DNA
was subjected to restriction digestion (SpeI-HF® and or
EcoRI of NEBL), and fragments were gel purified from
Fig. 7 A schematic depiction of heme-tolerance transporters described in streptococci. Putative homologs of the HrtAB (Class-3 ABC-type
transporter) were identified in GBS, and were shown to be induced by heme. The PefAB and PefCD are heme and PPIX efflux machineries
used by GBS. PefAB is related to the drug/proton antiporter family, while PefCD consists of Class-1 ABC type transporter. Our data show that
GAS employs PefCD to efflux heme and various antibacterial compounds
Table 3 Lists of primers used in this study
Primers name (Target) Restriction site (Use) Sequence (5’–3’) Source
ZE565 (pefC) EcoR1 GGGGAATTCTTATGGTGGGTCATTGTTG This study
ZE566 (pefC) EcoR1 AATGAATTCTAAGCGAGGGATGAGCTGTG This study
ZE634 (pefRCD) SpeI AAGGACTAGTGGTCTTGGCTAATAAGGCG This study
ZE635 (pefRCD) SpeI AGGGACTAGTTTGGGATTCATGTTAGCGAG This study
ZE553 (pefR) NA TGAGGAGACAACGATGCTTAAAGAC This study
ZE554 (pefC) ClaI AAAAAATCGATCAGGGTTGTTTGACTTAG This study
ZE458 (pefR) NA CACAAGTGATAGGTGATTTACGTG This study
ZE562 (pefR) NA CCTTGAGGACCTGCTAGATGCTCTAC This study
ZE649 (pefD) NA GGAGAATTGCAGCTGGCC This study
ZE650 (pefD) NA AGCTGGTGAACGCTGGTGC This study
ZE653 (pefC) NA GCGTTCAAGAAGGCCTTAAGTC This study
ZE654 (pefC) NA CCACCAACTCTGCGTGTGTTC This study
ZE581 (rpsL) NA CAGATTCACCAGCTTTGAAC [15]
ZE582 (rpsL) NA CAACACGAGTAGCAACG [15]
SpecFw NA GTGAGGAGGATATATTTGAATACATACGAA This study
SpecRev NA GTCCATTCAATATTCTCTCCAAGATAACTA This study
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agarose using S.N.A.P. UV-free gel purification kit (Invitro-
gen). The digested and gel purified fragments were ligated
using T4 DNA ligase (Roche) to generate a recombinant
construct. RT-PCR: RT-PCR was used to test if pefRCD
genes are co-expressed. Total RNA was extracted (90 min
after treatment with 3 μM heme) using the RiboPure™
Bacterial RNA isolation kit (Ambion™) and DNA con-
tamination was removed with DNase I (Ambion™). PCR
performed with 1 μg RNA as a template was used to
confirm the absence of DNA contaminations. cDNA was
synthesized from 0.8 μg RNA by reverse transcriptase
(ProtoScript® II, NEB) using the pefD antisense primer,
ZE650 (5 μM). The presence of pefR, pefC and pefD genes
in the cDNA was tested by PCR with the following primer
sets: ZE458/ZE562, ZE651/ZE652, and ZE649/ZE650
(Table 3). Real-Time RT-PCR (Q-PCR): Q-PCR was used
to compare the expression of the pefC and pefD genes be-
tween the wild type and the mutant strains. Briefly, 25 ng
of DNase-I digested, ultra-pure total RNA was added to
20 μl Power SYBR® green master mix (AB), containing en-
zyme and 200 nM of gene specific primers (ZE653/ZE654
for pefC and ZE649/ZE650 for pefD). The reactions were
preformed following the One Step RNA to CT protocol,
using 7500 Fast Real-Time PCR instrument (AB). Data ac-
quisition and analysis involved relative quantification with
comparative ΔΔCT process. The relative expression of the
pefC and pefD genes was normalized to rpsL transcript
levels, which was used as an endogenous control.
Construction of plasmids, GAS mutants and
complementation strains
The pefC::pMZ1 mutant, ZE4951, was constructed in
NZ131 background by Campball insertion using plasmid
pMZ1. Briefly, an internal 696 bp fragment from the
pefC gene was amplified from NZ131 chromosome using
ZE565 and ZE566 primers and ligated into the EcoRI
site in pUC-Spec, which carries the spectinomycin resist-
ance gene, aad9 [55]. The resulting plasmid, pMZ1, was
introduced into NZ131 strain and spectinomycin resistant
colonies were selected. The structure of the chromosomal
pefC::pMZ1 mutation was verified by PCR and sequence
analysis. For complementation analysis, a 4336 bp fragment
spanning the pefRCD operon including the promoter re-
gion was amplified from NZ131 chromosome with ZE634
and ZE635 primers and ligated into the SpeI site of the
shuttle vector, pKSM201 [56], which carries the kanamycin
resistance gene aphA3, generating pANKITA5b. The
plasmids pKSM201 (empty vector) and pANKITA5b
were introduced into ZE4951 strain by selection for
spectinomycin and kanamycin resistance.
Disc diffusion assay
GAS sensitivity was tested using the Disc Diffusion method
as previously described [15]. Briefly, sterile 8.0 mm
Whatman filter paper discs (with 1.2 mm width) were sub-
merged in doxorubicin (1.6 mM), heme (10 mM), ampicil-
lin (10 mM), erythromycin (10 mM), Hoechst 33342
(20 mM), ethidium bromide (24 mM) solutions or Norflox-
acin (10 μg, ready to use disc, OXOID), dried and impreg-
nated onto THYA that was plated with 0.1 ml (OD600nm =
0.1) of overnight GAS culture. The plates were incubated at
37 °C for 17 h before the zone of clearance around the discs
was measured.
Determination of lipid peroxidation using TBARS assay
Fresh THYB was inoculated with GAS cells collected
from plates: the inocula consisted of cells grown overnight
at 37 °C on THYA and suspended in saline. Bacterial sus-
pensions at OD600 = 0.5 were diluted 1:100 into fresh
THYB, incubated at 37 °C, and growth was monitored.
Heme (1 μM) was added at the logarithmic phase of
growth (~60–70 Klett units) and samples (standardized
according to cell density) were harvested by centrifugation
(5000 × g, 20 min at 4 °C) at 30, 60, and 90 min post
exposure. The cell pellets were washed and samples were
prepared and analyzed for lipid peroxidation using
OXI-TEK TBARS (Thiobarbituric Acid Reactive Sub-
stances) assay kit (ZeptoMatrix Corporation) as previously
described [15]. Sample absorbance at 532 nm was re-
corded using the DU 730 Life Science UV/vis spectro-
photometer. The A532 nm obtained for the experimental
samples were compared to a standard curve generated
using the malondialdehyde (MDA) reagent supplied
with the kit.
DNA damage detection
Fresh THYB medium was inoculated with GAS cells col-
lected from THYA plates as described above. The cultures
were treated with 5 μM heme at the logarithmic phase of
growth (~60–70 Klett units) and samples (standardized
according to cell density) were harvested at 0, 30 and
90 min post exposure. Genomic DNA was extracted from
the cell pellet using the ArchivePure DNA extraction kit
(5 PRIME). DNA purity and concentration were deter-
mined and 0.5 μg of DNA samples were used to quantify
the formation of apurinic/apyrimidinic (AP) sites using
the DNA damage detection kit (PromoKine) per the
manufacture instructions. Briefly, DNA (500 ng) was
incubated with aldehyde reactive probe containing biotin
tag (ARP) solution for 1 h at 37 °C. Glycogen and TE buf-
fer were added to the solution, the DNA was allowed to
precipitate at −20 °C for 10 min and then collected by cen-
trifugation at 13,000 rpm for 10 min at 4 °C. The pellet of
the biotin-tagged DNA was washed with 70 % ethanol,
air-dried, resuspended in 1 ml of TE buffer. The DNA
samples (60 μl) were added to 96 well ELISA plate and in-
cubated overnight at room temperature with DNA bind-
ing solution. The signal was developed after incubation
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with horseradish peroxidase (HRP)-streptavidin solution
and developer. The signal intensity was quantified spectro-
scopically at 650 nm. A standard plot depicting the ab-
sorbance at 650 nm as a function of the number of
standard AP sites of standard solution (0, 8, 16, 24, 32,
and 40 ARP sites/105 bp solution) was used to determine
the number of AP sites/105 bp DNA fragment in experi-
mental samples. As a positive control for AP site forma-
tion in GAS cells, we used cells exposed to 10 mM H2O2
solution for 1 h at 37 °C followed by genomic DNA ex-
traction, labeling, and detection similar to standards and
experimental samples (data not shown).
Determination of intracellular hemin content
Fresh THYB medium was inoculated with GAS cells col-
lected from plates as described above. The cultures were
treated with 3 μM heme at the logarithmic phase of
growth (60–70 Klett units) and samples (standardized
according to cell density) were collected 90 min post ex-
posure by centrifugation (8000 × g for 20 min at 4 °C).
The cell pellet was washed 5 times (10 ml phosphate
buffered saline, pH 7.0 each), resuspended in 2 ml of
DMSO, and subjected to sonication (20 % amplitude for
30 s.). Heme content in the cell lysate was determined
using the procedure described by Lombard et al. with
small modifications [50]. Briefly, 4 ml of experimental
samples along with hemin standard solutions (0–5 μM,
in DMSO) were subjected to acidified chloroform ex-
traction as follows: addition of 2 ml of 50 mM glycine
buffer, pH 2.0 then 0.1 ml of 4 N HCl (pH 2.0), 0.2 ml of
5 M NaCl (pH 2.0) and chloroform (2 ml) followed by
vigorous mixing for 10 s (6 times). The reactions were
incubated at room temperature for 1 min and the absorb-
ance by the organic phase was then determined. The ab-
sorbance at 388, 450 and 330 nm were recorded and fed
into the correction equation Ac = 2 ×A388 − (A450 + A330).
The plot of Ac corrected for standard heme concentra-
tions was used to extrapolate the hemin concentration in
experimental samples.
Conclusions
We established significant orthology between the GBS
PefCD and the system encoded by GAS. Moreover, our
in silico analysis suggests that the previously described
SatAB transporter from S. suis is an orthologous system
and that a pefRCD–like operon is also found in the mem-
bers of the pyogenic streptococci. The S. suis, SatAB, was
shown to transfer norfloxacin and ciprofloxacin [37]. In
GBS, the PefCD proteins export heme and PPIX [32]. Our
work here illustrates that PefCD in GAS exports heme as
well as a variety of structurally unrelated compounds. It
will be interesting to find out whether the PefCD system is
a MDR transporter that has heme as one of its substrates
in all of the streptococcal species, or if it has evolved
distinct substrate specificities among various species
reflecting differences in ecological niches and lifestyle.
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